SPRUCE BIOSCIENCES INC (SPRB) Stock Earnings & Estimates
USA - NASDAQ:SPRB - US85209E2081 - Common Stock
8.82 USD
+0.22 (+2.56%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 10.089M | 4.911M -51.32% | 1.02M -79.23% | -100.00% | 5.406M | 2.55M -52.83% | -100.00% | 27.596M | 84.181M 205.05% | 142.64M 69.44% | ||
| EBITDA YoY % growth | -47.21M -12.40% | -51.923M -9.98% | -56.105M -8.05% | -88.787M -58.25% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -47.28M -12.38% | -51.993M -9.97% | -56.151M -8.00% | -39.525M 29.61% | -41.106M -4.00% | -38.352M 6.70% | -49.091M -28.00% | -14.687M 70.08% | 12.241M 183.35% | 66.621M 444.24% | 122.7M 84.18% | |
| Operating Margin | N/A | -515.34% | -1,143.37% | -3,875.00% | N/A | -709.43% | -1,925.12% | N/A | 44.36% | 79.14% | 86.02% | |
| EPS YoY % growth | -1.96 -8.89% | -1.26 35.71% | -75.28 -5,874.60% | -65.03 13.62% | -11.54 82.26% | -10.73 6.98% | -1.03 90.45% | -0.14 86.07% | 0.13 192.86% | 0.60 353.85% | 1.06 76.27% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -15.87 -0.77% | -2.60 93.92% | -2.70 88.74% | -2.82 19.57% | -2.94 81.49% | -3.07 -18.04% |
| Revenue Q2Q % growth | -100.00% | -100.00% | ||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -9.384M 0.26% | -9.282M 61.44% | -9.588M 33.84% | -9.996M -271.32% | -10.506M -11.96% | -10.914M -17.58% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -3.50 78.79% | -19.51 | 16.01 | 82.06% |
| Q1 2025 Q2Q % growth | -24.00 -8,471.43% | -16.42 | -7.58 | -46.19% |
| Q4 2024 Q2Q % growth | -42.75 -17,712.50% | -16.07 | -26.69 | -166.11% |
| Q3 2024 Q2Q % growth | -15.75 -5,150.00% | -18.17 | 2.42 | 13.31% |
| Q2 2024 Q2Q % growth | -16.50 -5,056.25% | -24.54 | 8.04 | 32.77% |
| Q1 2024 Q2Q % growth | -0.28 30.00% | -0.30 | 0.02 | 5.11% |
| Q4 2023 Q2Q % growth | -0.24 48.94% | -0.39 | 0.15 | 39.07% |
| Q3 2023 Q2Q % growth | -0.30 37.50% | -0.36 | 0.06 | 16.76% |
| Q2 2023 Q2Q % growth | -0.32 37.25% | -0.40 | 0.08 | 20.04% |
| Q1 2023 Q2Q % growth | -0.40 20.00% | -0.37 | -0.03 | -8.26% |
| Q4 2022 Q2Q % growth | -0.47 -20.51% | -0.54 | 0.07 | 13.06% |
| Q3 2022 Q2Q % growth | -0.48 2.04% | -0.55 | 0.07 | 12.04% |
| Q2 2022 Q2Q % growth | -0.51 -2.00% | -0.54 | 0.03 | 4.76% |
| Q1 2022 Q2Q % growth | -0.50 -19.05% | -0.47 | -0.03 | -6.95% |
| Q4 2021 Q2Q % growth | -0.39 | -0.55 | 0.16 | 29.19% |
| Q3 2021 Q2Q % growth | -0.49 96.03% | -0.58 | 0.09 | 16.09% |
| Q2 2021 Q2Q % growth | -0.50 | -0.46 | -0.04 | -8.93% |
| Q1 2021 Q2Q % growth | -0.42 | -0.43 | 0.01 | 2.73% |
| Q4 2020 Q2Q % growth | -0.39 | -0.61 | 0.22 | 35.70% |
| Q3 2020 Q2Q % growth | -12.35 | -0.52 | -11.83 | -2,274.09% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -100.00% | 255K | -255K | -100.00% |
| Q1 2025 Q2Q % growth | -100.00% | 408K | -408K | -100.00% |
| Q4 2024 Q2Q % growth | 697K -75.86% | 902.7K | -205.7K | -22.79% |
| Q3 2024 Q2Q % growth | 602K -80.41% | 1.524M | -922K | -60.50% |
| Q2 2024 Q2Q % growth | 1.61M -25.64% | 1.525M | 85K | 5.57% |
| Q1 2024 Q2Q % growth | 2.002M 1.93% | 1.181M | 821K | 69.52% |
| Q4 2023 Q2Q % growth | 2.887M | 1.428M | 1.459M | 102.17% |
| Q3 2023 Q2Q % growth | 3.073M | 1.53M | 1.543M | 100.85% |
| Q2 2023 Q2Q % growth | 2.165M | 833.003K | 1.332M | 159.90% |
| Q1 2023 Q2Q % growth | 1.964M | 510K | 1.454M | 285.10% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -10103.3% | -10103.3% | -11084.2% | -11084.2% |
| Revenue | -100% | -100% | -37.5% | -37.5% |